Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party

• Ali Bazarbachi,
• Myriam Labopin,
• Giorgia Battipaglia,
• Azedine Djabali,
• Jakob Passweg,
• Gerard Socié,
• Edouard Forcade,
• Didier Blaise,
• Patrice Chevallier,
• Corentin Orvain,
• Jan J. Cornelissen,
• William Arcese,
• Sylvain Chantepie,
• Khowla Hashaishi,
• Jean El Cheikh,
• Michael Medinger,
• Jordi Esteve,
• Arnon Nagler,
• Mohamad Mohty

Affiliations

Ali Bazarbachi

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon;Department of Cell Biology, Anatomy and Physiological Sciences, American University of Beirut, Beirut, Lebanon

Myriam Labopin

Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hôpital Saint Antoine, Université Pierre and Marie Curie, INSERM, UMRs 938, Paris, France

Giorgia Battipaglia

Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hematology Department, Federico II University of Naples, Naples, Italy

Azedine Djabali

Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France

Jakob Passweg

University Hospital, Hematology, Basel, Switzerland

Gerard Socié

Hôpital Saint Louis, Department of Hematology – BMT, Paris, France

Edouard Forcade

CHU Bordeaux Hôpital Haut-leveque, Pessac, France

Didier Blaise

Programme de Transplantation and Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France

Patrice Chevallier

CHU Nantes, Department D’Hematologie, Nantes, France

Corentin Orvain

CHRU, Service des Maladies du Sang, Angers, France

Jan J. Cornelissen

Department of Hematology, Rotterdam, the Netherlands

William Arcese

Tor Vergata University of Rome, Stem Cell Transplant Unit, Policlinico Universitario Tor Vergata, Rome, Italy

Sylvain Chantepie

CHU CAEN, Institut d’Hématologie de Basse-Normandie, Caen, France

Khowla Hashaishi

Acute Leukemia Working Party of EBMT, Paris, France

Jean El Cheikh

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

Michael Medinger

University Hospital, Hematology, Basel, Switzerland

Jordi Esteve

Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain

Arnon Nagler

Acute Leukemia Working Party of EBMT, Paris, France;Chaim Sheba Medical Center, Tel-Hashomer, Israel

Mohamad Mohty

Acute Leukemia Working Party of EBMT, Paris, France;Hematology Department, Hôpital Saint Antoine, Service d’Hématologie et Thérapie Cellulaire, Paris, France;Hôpital Saint Antoine, Université Pierre and Marie Curie, INSERM, UMRs 938, Paris, France